Patient Square Capital LP CGEM Holdings History
Number of Shares
878,897.00
Current Holdings Value*
$6.65 Mil
% of Portfolio
2.75%
Total Estimate Gain
$-8.52 Mil
% of Total Estimate Gain
-55.28%
Patient Square Capital LP's Cullinan Therapeutics Inc Holding Summary
As of 2025-03-31, Patient Square Capital LP held 878,897.00 shares of Cullinan Therapeutics Inc(CGEM), totaling $6.65 Mil. This investment constitutes 2.75% of their stock portfolio, and Patient Square Capital LP now holds 1.49% of the outstanding Cullinan Therapeutics Inc(CGEM) stock.
The initial trade took place in 2024Q3. And since then Patient Square Capital LP has made 2 purchases of CGEM, at an average price of $17.53, for a total of 878,897.00 shares. Based on historical transaction data and CGEM's current price of $7.84, Patient Square Capital LP's estimated gain on his CGEM holdings is $-8.52 Mil, reflecting a -55.28% gain to date.
Patient Square Capital LP CGEM ($7.84) Holding Chart
Patient Square Capital LP CGEM ($7.84) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1